Arie Belldegrun Insider Trading $KITE Kite Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Arie Belldegrun.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Arie Belldegrun. Arie Belldegrun is Director in Talon Therapeutics, Inc. ($EMLR) and Director in Arno Therapeutics, Inc ($ARNI) and Director in Cougar Biotechnology, Inc. ($CGRB) and Chairman, President and CEO in Kite Pharma, Inc. ($KITE) and Director in UroGen Pharma Ltd. ($URGN) and in Allogene Therapeutics, Inc. ($ALLO) and Director in Allogene Therapeutics, Inc. ($ALLO) and Director in Kronos Bio, Inc. ($KRON).
Arie Belldegrun in Kite Pharma, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Arie Belldegrun: Chairman, President and CEO
Holdings: 159,160 shares
Current Value: $8,486,411
Latest Transaction: Oct 05 2017
$KITE Market Capitalization: $2.64B
$KITE Previous Close: $53.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Arie Belldegrun in Kite Pharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALLO, ARNI, CGRB, KITE, KRON, EMLR, URGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Option Exercise | D | 47.42 | 159,700 | 7,572,974 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Option Exercise | D | 63.87 | 56,643 | 3,617,788 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Option Exercise | D | 63.87 | 44,057 | 2,813,921 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Option Exercise | D | 51.96 | 43,500 | 2,260,260 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Option Exercise | D | 51.96 | 95,700 | 4,972,572 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Sell | D | 180.00 | 500,000 | 90,000,000 | 0 | 500 K to 0 (-100.00 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Sell | D | 180.00 | 500,000 | 90,000,000 | 0 | 500 K to 0 (-100.00 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Sell | D | 180.00 | 430,190 | 77,434,200 | 0 | 430.2 K to 0 (-100.00 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Sell | D | 180.00 | 159,329 | 28,679,220 | 0 | 159.3 K to 0 (-100.00 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Sell | D | 180.00 | 1,607,750 | 289,395,000 | 0 | 1.6 M to 0 (-100.00 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Sell | D | 0.00 | 159,160 | 0 | 0 | 159.2 K to 0 (-100.00 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Grant | A | 0.00 | 50,000 | 0 | 159,160 | 109.2 K to 159.2 K (+45.80 %) |
| Sep 27 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Sell | S | 179.66 | 26,347 | 4,733,605 | 109,160 | 135.5 K to 109.2 K (-19.44 %) |
| Sep 27 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Grant | A | 0.00 | 50,000 | 0 | 135,507 | 85.5 K to 135.5 K (+58.47 %) |
| May 09 2017 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Buy | P | 68.57 | 17,000 | 1,165,690 | 85,507 | 68.5 K to 85.5 K (+24.81 %) |
| Dec 29 2016 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Option Exercise | A | 47.72 | 159,700 | 7,620,884 | 159,700 | |
| Dec 29 2016 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Grant | A | 0.00 | 43,800 | 0 | 68,507 | 24.7 K to 68.5 K (+177.28 %) |
| Dec 29 2016 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Gift | G | 0.00 | 66,000 | 0 | 1,607,750 | 1.7 M to 1.6 M (-3.94 %) |
| Dec 22 2016 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Sell | S | 50.86 | 3,493 | 177,654 | 24,707 | 28.2 K to 24.7 K (-12.39 %) |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Option Exercise | A | 63.87 | 100,700 | 6,431,709 | 100,700 | |
| Dec 21 2015 | KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President ... | Grant | A | 0.00 | 28,200 | 0 | 28,200 | 0 to 28.2 K |
Page: 1